Risk Models for Advanced Melanoma Patients Under Anti-PD-1 Monotherapy—Ad hoc Analyses of Pooled Data From Two Clinical Trials

Background: The best response and survival outcomes between advanced melanoma patients treated with the anti-PD-1 monotherapy vary greatly, rendering a risk model in need to optimally stratify patients based on their likelihood to benefit from the said treatment. Methods: We performed an ad hoc anal...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Xue, Dai, Jie, Li, Caili, Cui, Chuanliang, Mao, Lili, Wei, Xiaoting, Sheng, Xinan, Chi, Zhihong, Yan, Xieqiao, Tang, Bixia, Lian, Bin, Wang, Xuan, Zhou, Li, Li, Siming, Kong, Yan, Qi, Zhonghui, Xu, Huayan, Duan, Rong, Guo, Jun, Si, Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174451/
https://www.ncbi.nlm.nih.gov/pubmed/34094921
http://dx.doi.org/10.3389/fonc.2021.639085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174451/
https://www.ncbi.nlm.nih.gov/pubmed/34094921
http://dx.doi.org/10.3389/fonc.2021.639085

Ejemplares similares